BSECompany Update3d ago · 22 Oct 2026, 01:01 pm

Medicine Authority European Union (EU)- conducted GMP inspection at Company''s Formulation manufacturing facility located at Khopoli is successfully concluded.

Kopran Ltd · 524280

✦ AI SummaryRegulatory

Kopran Ltd's formulation manufacturing facility at Khopoli successfully concluded a GMP inspection by the Medicine Authority European Union (EU) with one major and some minor observations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Attachments (1)

📄

471fe80c-3e0b-4123-a2f8-3e04b6982b32.pdf

pdf

Download →
View document text
October 22, 2026 The Manager The Manager BSE Limited The National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, P. J. Towers, Dalal Street, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 001. Mumbai – 400 051. BSE Scrip Code No. 524280 NSE Symbol: KOPRAN Subject: Press Release Dear Sir/Madam, “Closure of Medicine Authority European Union (EU)- conducted GMP inspection at the Company’s Formulation Please find enclosed a copy of press release dated October 22, 2026, titled manufacturing facility located at Khopoli.” This may kindly be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Regards, For Kopran Limited Sunil Sodhani Company Secretary & Compliance Officer Membership No. FCS 3897 KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111 Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078.Email: cs@kopran.com Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337• Fax: (02192) 274025 PRESS RELEASE “Closure of Medicine Authority European Union (EU) conducted GMP inspection at the Company’s Formulation manufacturing facility located at Khopoli.” Medicine Authority European Union (EU)- conducted GMP inspection at the Company’s Formulation, manufacturing facility located at Khopoli, from September 18, 2026 to September 23, 2026. The inspection was successfully concluded with No critical observations , one major observation and some minor observations and there were no data integrity related observations. The Company is in the process to submit the compliance responses to the EU authorities within a fortnight October 22, 2026 Mumbai KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111 Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078.Email: cs@kopran.com Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337• Fax: (02192) 274025